161 related articles for article (PubMed ID: 28754830)
1. Vascular Tissue-Type Plasminogen Activator Promotes Intracranial Aneurysm Formation.
Labeyrie PE; Goulay R; Martinez de Lizarrondo S; Hébert M; Gauberti M; Maubert E; Delaunay B; Gory B; Signorelli F; Turjman F; Touzé E; Courthéoux P; Vivien D; Orset C
Stroke; 2017 Sep; 48(9):2574-2582. PubMed ID: 28754830
[TBL] [Abstract][Full Text] [Related]
2. tPA-NMDAR Signaling Blockade Reduces the Incidence of Intracerebral Aneurysms.
Louet ER; Glavan M; Orset C; Parcq J; Hanley DF; Vivien D
Transl Stroke Res; 2022 Dec; 13(6):1005-1016. PubMed ID: 35307812
[TBL] [Abstract][Full Text] [Related]
3. Tissue-type plasminogen activator deficiency delays bone repair: roles of osteoblastic proliferation and vascular endothelial growth factor.
Kawao N; Tamura Y; Okumoto K; Yano M; Okada K; Matsuo O; Kaji H
Am J Physiol Endocrinol Metab; 2014 Aug; 307(3):E278-88. PubMed ID: 24918201
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory changes in the aneurysm wall: a review.
Tulamo R; Frösen J; Hernesniemi J; Niemelä M
J Neurointerv Surg; 2018 Jul; 10(Suppl 1):i58-i67. PubMed ID: 30037960
[TBL] [Abstract][Full Text] [Related]
5. Tissue-type plasminogen activator-induced invasion and metastasis of murine melanomas.
Alizadeh H; Ma D; Berman M; Bellingham D; Comerford SA; Gething MJ; Sambrook JF; Niederkorn JY
Curr Eye Res; 1995 Jun; 14(6):449-58. PubMed ID: 7671626
[TBL] [Abstract][Full Text] [Related]
6. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.
Pinsky DJ; Liao H; Lawson CA; Yan SF; Chen J; Carmeliet P; Loskutoff DJ; Stern DM
J Clin Invest; 1998 Sep; 102(5):919-28. PubMed ID: 9727060
[TBL] [Abstract][Full Text] [Related]
7. Lymphocytes influence intracranial aneurysm formation and rupture: role of extracellular matrix remodeling and phenotypic modulation of vascular smooth muscle cells.
Sawyer DM; Pace LA; Pascale CL; Kutchin AC; O'Neill BE; Starke RM; Dumont AS
J Neuroinflammation; 2016 Jul; 13(1):185. PubMed ID: 27416931
[TBL] [Abstract][Full Text] [Related]
8. Tissue plasminogen activator involvement in experimental autoimmune myasthenia gravis: aggravation and therapeutic potential.
Gur-Wahnon D; Mizrachi T; Wald-Altman S; Al-Roof Higazi A; Brenner T
J Autoimmun; 2014 Aug; 52():36-43. PubMed ID: 24423642
[TBL] [Abstract][Full Text] [Related]
9. Promotion of Wound Healing by an Agonist of Adenosine A2A Receptor Is Dependent on Tissue Plasminogen Activator.
Montesinos MC; Desai-Merchant A; Cronstein BN
Inflammation; 2015 Dec; 38(6):2036-41. PubMed ID: 25991438
[TBL] [Abstract][Full Text] [Related]
10. Increased bone formation in mice lacking plasminogen activators.
Daci E; Everts V; Torrekens S; Van Herck E; Tigchelaar-Gutterr W; Bouillon R; Carmeliet G
J Bone Miner Res; 2003 Jul; 18(7):1167-76. PubMed ID: 12854826
[TBL] [Abstract][Full Text] [Related]
11. Interferon γ and plasminogen activator inhibitor 1 regulate adhesion formation after partial hepatectomy.
Ohashi K; Yoshimoto T; Kosaka H; Hirano T; Iimuro Y; Nakanishi K; Fujimoto J
Br J Surg; 2014 Mar; 101(4):398-407. PubMed ID: 24536011
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling reveals distinct molecular signatures associated with the rupture of intracranial aneurysm.
Nakaoka H; Tajima A; Yoneyama T; Hosomichi K; Kasuya H; Mizutani T; Inoue I
Stroke; 2014 Aug; 45(8):2239-45. PubMed ID: 24938844
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of Intracranial Aneurysms: COX-2 Expression, Iron Deposition in Aneurysm Wall, and Correlation With Magnetic Resonance Imaging.
Rodemerk J; Junker A; Chen B; Pierscianek D; Dammann P; Darkwah Oppong M; Radbruch A; Forsting M; Maderwald S; Quick HH; Zhu Y; Jabbarli R; Sure U; Wrede KH
Stroke; 2020 Aug; 51(8):2505-2513. PubMed ID: 32646326
[TBL] [Abstract][Full Text] [Related]
14. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
[TBL] [Abstract][Full Text] [Related]
15. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia.
Tsuji K; Aoki T; Tejima E; Arai K; Lee SR; Atochin DN; Huang PL; Wang X; Montaner J; Lo EH
Stroke; 2005 Sep; 36(9):1954-9. PubMed ID: 16051896
[TBL] [Abstract][Full Text] [Related]
16. Involvement of tissue plasminogen activator-plasmin system in depolarization-evoked dopamine release in the nucleus accumbens of mice.
Ito M; Nagai T; Kamei H; Nakamichi N; Nabeshima T; Takuma K; Yamada K
Mol Pharmacol; 2006 Nov; 70(5):1720-5. PubMed ID: 16908600
[TBL] [Abstract][Full Text] [Related]
17. Coordinated expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 during corpus luteum formation and luteolysis in the adult pseudopregnant rat.
Liu K; Brändström A; Liu YX; Ny T; Selstam G
Endocrinology; 1996 May; 137(5):2126-32. PubMed ID: 8612557
[TBL] [Abstract][Full Text] [Related]
18. The glycocalyx protects erythrocyte-bound tissue-type plasminogen activator from enzymatic inhibition.
Ganguly K; Murciano JC; Westrick R; Leferovich J; Cines DB; Muzykantov VR
J Pharmacol Exp Ther; 2007 Apr; 321(1):158-64. PubMed ID: 17215448
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of genome-wide gene expression profiles in ruptured and unruptured human intracranial aneurysms.
Marchese E; Vignati A; Albanese A; Nucci CG; Sabatino G; Tirpakova B; Lofrese G; Zelano G; Maira G
J Biol Regul Homeost Agents; 2010; 24(2):185-95. PubMed ID: 20487632
[TBL] [Abstract][Full Text] [Related]
20. Bone resorption and response to calcium-regulating hormones in the absence of tissue or urokinase plasminogen activator or of their type 1 inhibitor.
Leloup G; Lemoine P; Carmeliet P; Vaes G
J Bone Miner Res; 1996 Aug; 11(8):1146-57. PubMed ID: 8854251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
